Stay updated on Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial
Sign up to get notified when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.

Latest updates to the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page
- Check7 days agoChange DetectedThe history now shows that the study is no longer recruiting participants, indicating recruitment has ceased. The revision tag was updated to v3.6.0, replacing the previous v3.5.5 entry in the version history.SummaryDifference0.3%

- Check14 days agoChange DetectedA new site revision label v3.5.5 is added to the record history, replacing the former v3.5.4 label and updating the documented version of the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe Record History now lists a new latest revision, v3.5.4, and the previous v3.5.3 entry is removed. This indicates a new build/version of the page rather than changes to study data or content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a newer version of the page history. This reflects a refreshed metadata entry in the study record history.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history now shows a new revision entry v3.5.2 and removes v3.5.0, indicating a small site update.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Health-Related QoL in Myeloma: Daratumumab vs Lenalidomide Clinical Trial page.